Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07172334

What is the Role of the Exposome in Pulmonary Hypertension

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Poitiers University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Pulmonary arterial hypertension (PAH) is a rare and incurable disease affecting people of all ages. It is characterized by obstructive remodeling of the small pulmonary arteries, responsible for an increase in pulmonary arterial pressure, leading to right heart failure and death in the absence of treatment. PAH can be associated with a variety of diseases, but around half of all PAH cases are idiopathic or hereditary, and may develop on predisposed terrain following a "second hit", as suggested by the identification of PAH cases associated with the use of anorectic drugs, methamphetamine and occupational exposure to organic solvents. No study has systematically analyzed the exposome of patients with PAH, combining environmental and occupational exposures as well as drugs and medications. The exposome of patients with PAH without associated causes will be compared with that of patients with another form of pulmonary hypertension (PH), linked to thromboembolic risk factors: chronic thromboembolic PH (CTEPH), which will constitute the control group.

Conditions

Interventions

TypeNameDescription
OTHERQuestionnairesPatients will complete questionnaires on professional exposures with the help of a trained professional (estimated time: 30 minutes), followed by self-questionnaires on indoor and outdoor pollution, medications, drugs and socio-economic variables (estimated time: 30 minutes).
OTHERSamplesTwo strands of hair (or beard or axillary hair) will be taken, along with a urine and blood sample.

Timeline

Start date
2026-07-01
Primary completion
2028-07-01
Completion
2028-07-01
First posted
2025-09-15
Last updated
2026-02-13

Source: ClinicalTrials.gov record NCT07172334. Inclusion in this directory is not an endorsement.